American Century Companies’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
5VM
SCM
OM
O
American Century Companies's ZNTL Position: Q2 2026 in Review
American Century Companies increased its Zentalis Pharmaceuticals (ZNTL) stake by 101% in Q2 2026, buying an estimated $196K and bringing the position to 97,757 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.
American Century Companies first reported a position in ZNTL in Q2 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.
- American Century Companies held 97,757 shares of Zentalis Pharmaceuticals worth $474K as of Q2 2026.
- American Century Companies bought 49,185 Zentalis Pharmaceuticals shares in Q2 2026, an estimated $196K.
- Zentalis Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2592 holding.
- American Century Companies first reported a position in Zentalis Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.